Skip to main content

Table 4 Univariate survival analysis (Kaplan-Meier)

From: ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression

Characteristic

No. of cases

No. of events

Two-year survival rate (± SE) in %

p-value

ADAM9 expression

   

0.026

low

71

10

85.9 ± 4.1

 

high

37

12

70.3 ± 7.5

 

pT-status

   

< 0.001

pT1

54

2

96.3 ± 2.6

 

pT2/3/4

54

20

64.8 ± 6.5

 

Grading

   

0.001

G 1

11

0

-

 

G 2

75

12

85.3 ± 4.1

 

G 3/4

22

10

54.5 ± 10.6

 

pN-status

   

0.001

pN0

51

10

80.4 ± 5.6

 

pN1+

12

8

41.7 ± 14.2

 

Residual tumour

   

< 0.001

R0

78

10

87.2 ± 3.8

 

R1/2

15

8

46.7 ± 12.9

 

Metastasis

   

< 0.001

M0

85

8

90.6 ± 3.2

 

M1

23

14

43.5 ± 10.3

 
  1. Survival times of patients with renal cancer according to clinico-pathological characteristics and ADAM9 protein expression.